Aðalgeir Arason - Concepedia

Author

Aðalgeir Arason

National University Hospital of Iceland ORCID

Also Known As

A Arason, A. Arason, Adalgeir Arason, Ana Osorio, Audrey Lemaçon, Aðalgeir Arason, Ignacio Blanco, Katarzyna Durda, Kristiina Aittomäki, Lidia Feliubadalo

Publications

12.5K

Citations

H-Index

Concepts

All Affiliations

National University Hospital of Iceland University of Iceland Lund University Reykjavík University Helsinki University Hospital

About

Aðalgeir Arason is an author at National University Hospital of Iceland specializing in medicine, cancer genetics, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	18	5.2K
2	Health Sciences	3	3	271
3	Public Health	3	3	540
4	Engineering	1	1	157
5	Biostatistics	1	1	13

Aðalgeir Arason

Publications

11.3K

Citations

H-Index

Page 1

	Year	Citations
Identification of the breast cancer susceptibility gene BRCA2 Richard Wooster, Graham R. Bignell, Jonathan Lancaster, Nature Breast OncologyCancer GenomicsBreast CancerCancer GeneticsMedicine	1995	3.6K
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families Deborah Ford, Douglas F. Easton, Michael R. Stratton, The American Journal of Human Genetics	1998	3K
Pathology of Breast and Ovarian Cancers among <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from the Consortium of Investigators of Modifiers of <i>BRCA1</i> / <i>2</i> (CIMBA) Nasim Mavaddat, Daniel Barrowdale, Irene L. Andrulis, Cancer Epidemiology Biomarkers & Prevention	2012	649
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer Timothy R. Rebbeck, Nandita Mitra, Fei Wan, JAMA	2015	484
Mutational spectrum in a worldwide study of 29,700 families with<i>BRCA1</i>or<i>BRCA2</i>mutations Timothy R. Rebbeck, Tara M. Friebel, Eitan Friedman, Human Mutation Brca1 MutationsGenetic TestingGeneticsGenetic EpidemiologyMolecular Genetics	2018	298
RAD51 135G→C Modifies Breast Cancer Risk among BRCA2 Mutation Carriers: Results from a Combined Analysis of 19 Studies Antonis C. Antoniou, Olga M. Sinilnikova, Jacques Simard, The American Journal of Human Genetics Genome InstabilityBreast OncologyBrca2 Mutation CarriersCancer EpidemiologyCancer Risk	2007	242
High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients. Guðrún Jóhannesdóttir, Aðalgeir Arason, Bjarni A. Agnarsson, PubMed Breast OncologyCancer PathologyEpidemiology Of CancerGenetic EpidemiologyGynecology	1996	229
Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics Göran Jönsson, Johan Staaf, Johan Vallon‐Christersson, Breast Cancer Research	2010	194
Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus Tommi Kainu, Suh‐Hang Hank Juo, Richard Desper, Proceedings of the National Academy of Sciences	2000	185
Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13. Guðrún Jóhannesdóttir, Aðalgeir Arason, Sigurður Ingvarsson, PubMed Cancer PathologyCytogeneticsGeneticsPathologyTumor Biology	1995	159

Page 1